BRPI0417993A - anticorpo anti-cd52 para tratamento da diabetes - Google Patents

anticorpo anti-cd52 para tratamento da diabetes

Info

Publication number
BRPI0417993A
BRPI0417993A BRPI0417993-5A BRPI0417993A BRPI0417993A BR PI0417993 A BRPI0417993 A BR PI0417993A BR PI0417993 A BRPI0417993 A BR PI0417993A BR PI0417993 A BRPI0417993 A BR PI0417993A
Authority
BR
Brazil
Prior art keywords
antibody
diabetes treatment
treatment
diabetes
campath
Prior art date
Application number
BRPI0417993-5A
Other languages
English (en)
Inventor
Larry E Arthaud
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of BRPI0417993A publication Critical patent/BRPI0417993A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"ANTICORPO ANTI-CD52 PARA TRATAMENTO DA DIABETES". A presente invenção refere-se a prevenção e/ou tratamento da diabetes melito do tipo 1, com anticorpos específicos para CD52, por exemplo, CAMPATH-1H.
BRPI0417993-5A 2003-12-22 2004-12-22 anticorpo anti-cd52 para tratamento da diabetes BRPI0417993A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53205903P 2003-12-22 2003-12-22
PCT/US2004/043142 WO2005062893A2 (en) 2003-12-22 2004-12-22 Anti-cd52 antibody treatment for diabetes

Publications (1)

Publication Number Publication Date
BRPI0417993A true BRPI0417993A (pt) 2007-04-27

Family

ID=34738737

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417993-5A BRPI0417993A (pt) 2003-12-22 2004-12-22 anticorpo anti-cd52 para tratamento da diabetes

Country Status (8)

Country Link
US (1) US20070286857A1 (pt)
EP (1) EP1696956A4 (pt)
JP (1) JP2007515492A (pt)
CN (1) CN1956731A (pt)
BR (1) BRPI0417993A (pt)
CA (1) CA2548947A1 (pt)
IL (1) IL176282A0 (pt)
WO (1) WO2005062893A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201109238D0 (en) * 2011-06-01 2011-07-13 Antitope Ltd Antibodies
EP2750690B1 (en) * 2011-11-15 2018-11-07 The Walter and Eliza Hall Institute of Medical Research Soluble mediator
KR102437522B1 (ko) 2012-05-25 2022-08-26 셀렉티스 면역요법을 위한 동종이형 및 면역억제제 저항성인 ｔ 세포의 조작 방법
US20150017136A1 (en) * 2013-07-15 2015-01-15 Cellectis Methods for engineering allogeneic and highly active t cell for immunotherapy
AU2013344807B2 (en) 2012-11-15 2018-05-24 The Walter And Eliza Hall Institute Of Medical Research Soluble mediator
US11077144B2 (en) 2013-05-13 2021-08-03 Cellectis CD19 specific chimeric antigen receptor and uses thereof
US11311575B2 (en) * 2013-05-13 2022-04-26 Cellectis Methods for engineering highly active T cell for immunotherapy
WO2016176089A1 (en) 2015-04-29 2016-11-03 Kardiatonos, Inc. Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022547D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Purified immunoglobulin

Also Published As

Publication number Publication date
WO2005062893A3 (en) 2005-12-29
EP1696956A4 (en) 2007-08-01
EP1696956A2 (en) 2006-09-06
CA2548947A1 (en) 2005-07-14
IL176282A0 (en) 2006-10-05
WO2005062893A2 (en) 2005-07-14
JP2007515492A (ja) 2007-06-14
CN1956731A (zh) 2007-05-02
US20070286857A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
NZ593289A (en) Anti-neuropilin-1 antibodies for treating angiogenesis
BRPI0506771A (pt) anticorpo, e, composição farmacêutica
TR200200472T2 (tr) Anti-Erb B2 antikorları ile tedavi için dozajlar
BRPI0511008A (pt) agentes de ligação de il-13
MA30557B1 (fr) Composés de pyrrolopyrimidine et leurs utilisations.
MY143215A (en) Multifocal lenses for pre-presbyopic individuals
WO2007056457A3 (en) Methods, compositions, and kits for the treatment of medical conditions
BE2012C005I2 (pt)
IL185754A0 (en) Novel anti-plgf antibody
ATE470676T1 (de) Anti-vegf-2 antikörper
BRPI0507608A (pt) formulações de anticorpos anti-egfr lìquidas altamente concentradas
BR0317872A (pt) Medicamentos antiinflamatórios
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
DE602006015438D1 (de) Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
MX2009012950A (es) ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS.
WO2008134724A3 (en) Methods for administering anti-il-5 antibodies
WO2003055979A3 (en) ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS
BRPI0606148A2 (pt) anticorpos monoclonais neutralizantes contra a sìndrome respiratória aguda grave associada com o coronavìrus
BRPI0412265A (pt) uso de calcitonina em osteoartrite
BR0309095A (pt) Uso de osteoprotegerina para o tratamento e/ou prevenção de doença fibrótica
BRPI0417993A (pt) anticorpo anti-cd52 para tratamento da diabetes
WO2007068750A3 (en) Immunoglobulins directed against nogo
ATE495751T1 (de) Behandlung von bauchspeicheldrüsenkrebs mit einem monoklonalen antikörper
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
WO2004069860A3 (en) Isg15-conjugated proteins

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.